A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141

Asian Patients ◽

Recurrent Squamous Cell Carcinoma ◽

Open Label Phase ◽

Global Population

003 A single-arm, open-label phase III clinical trial of autologous fibroblast transplantation for facial contour deformities; long-term follow up

Journal of Investigative Dermatology ◽

10.1016/j.jid.2016.06.020 ◽

2016 ◽

Vol 136 (9) ◽

pp. S161

Author(s):

S. Shafieyan ◽

A. Bajouri ◽

N. Aghdami

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Open Label ◽

Facial Contour ◽

Open Label Phase ◽

Long Term Follow Up

Measurement of viral interferon sensitivity in patients with chronic hepatitis C. Prospective, randomised, open label phase III clinical trial

Journal of Hepatology ◽

10.1016/s0168-8278(02)80486-x ◽

2002 ◽

Vol 36 ◽

pp. 135-136 ◽

Cited By ~ 5

Author(s):

Wolfgang Vogel ◽

Harald Brunner ◽

Werner Lin ◽

Rudolf Stauber ◽

Karin Ptacek-Wegerer ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Open Label ◽

Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma

Value in Health ◽

10.1016/j.jval.2018.04.318 ◽

2018 ◽

Vol 21 ◽

pp. S38

Author(s):

N Rahhali ◽

Y Chalem ◽

J Niemira ◽

CW van Gils ◽

C Blome ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Open Label ◽

Patient Reported ◽

Open Label Phase ◽

Braf Mutant

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13922 ◽

2019 ◽

Vol 22 (4) ◽

pp. 540-548 ◽

Cited By ~ 4

Author(s):

Eiichi Araki ◽

Hirotaka Watada ◽

Yasuko Uchigata ◽

Osamu Tomonaga ◽

Hitomi Fujii ◽

...

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial

Annals of Oncology ◽

10.1093/annonc/mdz388 ◽

2019 ◽

Vol 30 (11) ◽

pp. 1831-1839 ◽

Cited By ~ 2

Author(s):

Y. Guo ◽

M.-J. Ahn ◽

A. Chan ◽

C.-H. Wang ◽

J.-H. Kang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Line Treatment ◽

Second Line ◽

Open Label ◽

Phase Iii Trial ◽

Asian Patients ◽

Metastatic Squamous Cell Carcinoma ◽

Head Neck

A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus

Annals of Oncology ◽

10.1093/annonc/mdw371.03 ◽

2016 ◽

Vol 27 ◽

pp. vi207 ◽

Cited By ~ 1

Author(s):

H. Yang ◽

J. Fu ◽

M. Liu ◽

Y. Chen ◽

Z. Chen ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Neoadjuvant Chemoradiotherapy ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Carcinoma Of The Esophagus ◽

Phase Iii Clinical Trial

PCN141 Quality of Life in Small Cell Lung Cancer: Results of an Open-Label Phase III Clinical Trial

Value in Health ◽

10.1016/j.jval.2011.08.1242 ◽

2011 ◽

Vol 14 (7) ◽

pp. A460

Author(s):

S. Hudgens ◽

J. King ◽

Z.M. Khan

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Clinical Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Open Label ◽

Review for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/review3 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Decision letter for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/decision1 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

F-048A PHASE III CLINICAL TRIAL OF NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE OESOPHAGUS (NEOCRTEC5010)

Interactive Cardiovascular and Thoracic Surgery ◽

10.1093/icvts/ivx280.048 ◽

2017 ◽

Vol 25 (suppl_1) ◽

Author(s):

J Fu ◽

M Liu ◽

Y Chen ◽

Z Chen ◽

C Zhu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Neoadjuvant Chemoradiotherapy ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Phase Iii Clinical Trial